'Malignant'Middle Cerebral Artery Territory Infarction
Arch Neurol 53:309-315, Macke,W.,et al, 1996
Medical Complications Among Hospitalizations for Ischemic Stroke in the United States from 1998 to 2007
Stroke 41:980-986, Tong,X., et al, 2010
Intracerebral Haemorrhage
Lancet 373:1632-1644, Qureshi,A.I.,et al, 2009
Post-Stroke Movement Disorders; Report of 56 Patients
JNNP 75:1568-1574, Alarcon,F.,et al, 2004
Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 34:1056-1083, Adams,H.P.,et al, 2003
Open-Label Dose-Titration Safety and Efficacy Study of Tizanidine Hydrocholoride in the Treatment of Spasticity Associated With Chronic Stroke
Stroke 32:1841-1846, Gelber,D.A.,et al, 2001
Early Clinical and Radiological Predictors of Fatal Brain Swelling in Ischemic Stroke
Stroke 30:287-292, Krieger,D.W.,et al, 1999
Intellectual Decline After Stroke, The Framingham Study
Stroke 29:805-812, Kase,C.S.,et al, 1998
Mass Effect and Death from Severe Acute Stroke
Neurol 49:1090-1095, Pullicino,P.M.,et al, 1997
Medical Complications During Stroke Rehabilitation
Stroke 26:990-994, Kalra,L.,et al, 1995
Complications of Acute Stroke
Lancet 339:721-724, Oppenheimer,S.&Hachinski,V., 1992
Results of the Seven-Year Prospective Study of Stroke Patients
Stroke 19:942-949, Scmidt,E.V.,et al, 1988
The Natural History of Asymptomatic Carotid Artery Occlusive Lesions
JAMA 258:2704-2707, Meissner,I.,et al, 1987
Newer Concepts of Cerebral Vascular Disease
Med Clin North Am 54:1970., Meyer,J., 1970
Atherosclerotic CVD-Its Nature & Management
Am J Med 46:763, Heyden,S.,et al, 1969